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Background: Retroviral integration depends on the interaction between intasomes, host chromatin and cellular
targeting cofactors as LEDGF/p75 or BET proteins. Previous studies indicated that the retroviral integrase, by itself,
may play a role in the local integration site selection within nucleosomal target DNA. We focused our study on this
local association by analyzing the intrinsic properties of various retroviral intasomes to functionally accommodate
different chromatin structures in the lack of other cofactors.
Results: Using in vitro conditions allowing the efficient catalysis of full site integration without these cofactors, we
show that distinct retroviral integrases are not equally affected by chromatin compactness. Indeed, while PFV and
MLV integration reactions are favored into dense and stable nucleosomes, HIV-1 and ASV concerted integration
reactions are preferred into poorly dense chromatin regions of our nucleosomal acceptor templates. Predicted
nucleosome occupancy around integration sites identified in infected cells suggests the presence of a nucleosome
at the MLV and HIV-1 integration sites surrounded by differently dense chromatin. Further analyses of the relationships
between the in vitro integration site selectivity and the structure of the inserted DNA indicate that structural constraints
within intasomes could account for their ability to accommodate nucleosomal DNA and could dictate their capability to
bind nucleosomes functionally in these specific chromatin contexts.
Conclusions: Thus, both intasome architecture and compactness of the chromatin surrounding the targeted nucleosome
appear important determinants of the retroviral integration site selectivity. This supports a mechanism involving a global
targeting of the intasomes toward suitable chromatin regions followed by a local integration site selection modulated by
the intrinsic structural constraints of the intasomes governing the target DNA bending and dictating their sensitivity
toward suitable specific nucleosomal structures and density.
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The retroviral replication requires the integration of viral
DNA into the host genome. This step, catalyzed by
retroviral integrase (IN), is performed within a nucleo-
protein structure, the pre-integration complex (PIC),
which must reach the nucleus and gain access to the tar-
get DNA in a nucleosomal compacted structure [1,2].
During the integration process, IN first removes two nu-
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unless otherwise stated.generated during reverse transcription, which is called
the 3′ processing reaction. The newly exposed 3′OH
groups are then used in the concerted nucleophilic at-
tack of two phosphodiester bonds across the major
groove of the host DNA, a reaction termed joining or
strand transfer [3-6]. Post-integration DNA reparation
(PIR) of this integration intermediate, leading to the es-
tablishment of the provirus, generates short target DNA
duplications. The size of these duplications varies among
retroviruses: 4 bp in the case of the Spumaretrovirus,
prototype foamy virus (PFV) and the Gammaretrovirus,
murine leukemia virus (MLV), 5 bp for the Lentivirus,
human immunodeficience virus (HIV) and 6 bp for theral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Beta- and Deltaretroviruses [7]. This size corresponds to
the distance between the phosphodiester bonds of cellu-
lar DNA attacked by the two viral DNA ends during
concerted integration process. This distance is dictated
by physical constraints within the intasomes, as the
space between the two functional catalytic sites, govern-
ing the bending of the target DNA [8-10].
Retroviral INs comprise three distinct structural and
functional domains: the N–terminal domain (which is pre-
ceded by an additional domain, the N-terminal extension
domain (NED), in Spumaretroviral, Gamma- and Epsilon-
retroviral INs), adopts an HTH-fold and is characterized
by the presence of an HHCC zinc finger–like motif; the
core domain, structurally related to Escherichia coli RNase
H and other polynucleotidyl-transferases, contains the in-
variant acidic triad DDE involved in the coordination of
the catalytic cofactors; and the C–terminal domain, the
least conserved among retroviral INs, includes an SH3-
fold [11,12] for recent reviews). Although numerous par-
tial structures of INs from different retroviral genera have
been determined, only PFV IN has been crystallized in its
full-length form, in the presence of its DNA substrates,
providing unprecedented details on the organization of
the successive nucleoprotein complexes involved in the in-
tegration process, from the stable synaptic complex (SSC,
also referred to as the intasome) to the strand transfer
complex (STC) [8-10]. In agreement with these structural
data, previous biochemical studies performed on INs from
different retroviruses have also concluded that the integra-
tion reaction was carried out by an IN tetramer [13-15],
although the global architecture of the intasome and the
STC might vary from a system to another [16,17]. Al-
though IN alone can catalyze integration in vitro, other
cellular or viral proteins have been found to play an im-
portant role in infected cells within the pre-integration
complex (PIC) or during transit to the nucleus (for a re-
view on the IN cofactors see [18]). Furthermore some
post-translational modifications of HIV-1 IN have been re-
ported that could also affect the enzyme activity and its
cellular behavior [19,20].
The integration boundaries mark the definitive position
of the provirus, and the site selection is highly important
for the outcome of the infection. Integration into a region
of active transcription promotes viral gene expression,
whereas integration into transcriptionally repressed chro-
matin could potentially promote viral latency [21-23]. If
HIV-1 DNA is integrated into actively transcribed genes,
the viral genes would need to be repressed to allow per-
sistence of the infection. The mechanisms that control
viral gene expression are not yet understood fully. Several
factors are involved in the infection of latent and resting
cells and in the preferential integration found at the per-
iphery of the nucleus in such latent T cells [24-26]. On theother hand, for the host, integration events can lead to the
activation of proto-oncogenes or the inactivation of essen-
tial cellular genes [27]. For all these reasons it appears es-
sential to elucidate the molecular mechanisms governing
integration site selection to set up safe and efficient gene
therapy approaches.
To this end, genome-wide studies have been undertaken
and have revealed that retroviruses target different regions
of the host chromatin. These studies have shown that some
members of the Spumaretrovirus and Gammaretrovirus
families favor transcription start sites of actively transcribed
genes (TSSs) and CpG islands, the Lentiviruses that have
been studied integrate preferentially into active transcrip-
tion units (TUs), the Alpha– and Deltaretroviruses tested
exhibit only a weak preference for TUs, and some Betare-
troviruses integrate in an almost random fashion (reviewed
in [28]). Globally, retroviruses can thus be classified into
three separate categories: those that preferentially target
TSSs and CpG islands, those that display a strong bias to-
ward integration into TUs and those that exhibit little or
no particular preference for any chromosomal feature.
Interestingly these three groups comprise viruses that share
the same target site duplication signature as mentioned
above. This raises the question of the relationship between
these genomic signatures, closely linked to intasome struc-
tures and target DNA bending, and integration selectivity.
HIV-1 and MLV integration site preferences have been
shown to rely essentially on the interaction of IN with spe-
cific host cell factors - i.e. lens epithelium-derived growth
factor (LEDGF/p75) (see [29] for a review) and bromodo-
main and extraterminal domain (BET) proteins [30,31], re-
spectively - that recognize defined transcription-associated
histone modifications. On the other hand, cellular data
obtained from a murine LEDGF/p75 knock-out (KO)
model have shown that LEDGF/p75 was not involved in
the local target DNA sequence preference associated with
HIV-1 integration [32-34]. Thus, despite its ability to bind
histone tails through its PWWP domain [35], LEDGF/
p75 is unlikely the sole protein responsible for targeting
integration into nucleosomal DNA which may require add-
itional intasome/nucleosome interactions and/or chromatin-
remodeling activities [36]. Recently it has been shown
that dissociating the interaction between MLV integrase
and BET proteins did not change the local integration
site sequence selection [37]. Furthermore, in the lack of
LEDGF/p75, the local HIV-1 integration sequence se-
lectivity was also shown unchanged [38,39]. Taken to-
gether all these data suggest that integrase protein plays
a role in the local targeting to the nucleosomal locus
after targeting of the intasome into suitable regions of
the chromatin thanks to its interaction with cellular co-
factors. We, thus, focused our work on the better deter-
mination of this final local association between IN and
nucleosomes.
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somes and nucleosomes in cells remains elusive. There
are no preferential positions for nucleosomes across the
majority of the human genome [40]. Consequently, the
dynamic nature of chromatin makes it difficult to accur-
ately predict the positions of nucleosomes in the cell.
For this reason, in vitro approaches based on the use of
chromatinized templates, in which nucleosome position-
ing is exclusively sequence-driven, are valuable for un-
derstanding the specific influence of the chromatin
structure on retroviral integration site selectivity. Early
results showed that DNA distorsion and nucleosome
could favor retroviral integration in vitro [41-46]. More
recently, in vitro study using chromatinized template has
shown that HIV-1 integration into nucleosomes could
be modulated by chromatin structure and dynamics
[36]. Additionally, partial one end and physiological two
ends concerted HIV-1 integration reactions were shown
to be affected differently by chromatin in vitro suggest-
ing that the structure of the different intasomes catalyz-
ing these various integration reactions could impact
their sensitivity to nucleosomal DNA [36].
In order to determine how integration could be modu-
lated both by chromatin structure and intasome archi-
tecture, we compared the ability of various retroviral
intasomes to accommodate different chromatin structures
both in vitro and in vivo. We selected retroviral integrases
that vary in their integration site preference in infected
cells and in the size of the duplicated target site sequence
governed by the distance separating the two active sites
of the intasome and, thus, the architecture of the IN
catalytic pocket. To determine the intrinsic sensitivity of
the selected integrases toward chromatin compactness
was determined by analyzing their integration efficiency,
selectivity and fidelity in naked and nucleosomal DNA
in vitro using specific biochemical conditions allowing effi-
cient full site integration reactions in the lack of cofactors.
Our results indicate that the impact of the chromatin
structure at the integration site is mainly driven by intrin-
sic physical constraints within the retroviral intasomes.
These constraints could thus dictate their capability to
bind nucleosomes functionally in specific chromatin con-
texts after targeting into specific regions of the host gen-
ome via the interaction with cellular cofactors.
Results
In vitro integration catalyzed on chromatin by integrases
from various retroviral genera
HIV-1, PFV, MLV and ASV INs were compared using
their specific donor DNAs (described in Additional file
1: Figure S1) and p5S acceptor plasmids derived from
the previously described pBSK-Zeo-S5G5E4 receptor
vector (Figure 1A and Additional file 2: Figure S2A) con-
taining a 5S-G5E4 fragment carrying two times fiverepeats of 5S sequences surrounding a central sequence
containing five gal4 DNA binding sites and the adeno-
virus 2 E4 minimal promoter. This construct allows the
in vitro association of nucleosomes in stable, regularly
spaced and defined positions of the DNA template lead-
ing to dense polynucleosome (PN) [36]. A nucleosome
positioning prediction algorithm performed on the acceptor
plasmid sequence (Figure 1B) shows that it contains two re-
gions allowing the formation of different chromatin struc-
ture after nucleosomes assembly. Nucleosomes assembly in
region 1, containing the 5S-G5E4 fragment, leads to dense,
highly organized and stable chromatin. In contrast, assem-
bly in region 2, corresponding to the pBSK-Zeo backbone,
allows the formation of nucleosomes in a less dense, more
dynamic and less organized chromatin structure.
The overall chromatin structure of the plasmid was first
checked by DNase 1 protection after nucleosomes assembly
with increasing amounts of the native core histones, H3,
H4, H2A and H2B (Additional file 2: Figure S2B). Then,
typical restriction assays (REA) using restriction enzymes
cutting distinctively in both regions (see Additional file 2:
Figure S2A and S2C) showed that the 5S-G5E4 containing
domain 1 was poorly accessible, unlike region 2 which
remained highly sensitive to DNA cleavage. This confirmed
the two distinct chromatin structural regions (regions 1,
densely occupied and region 2 sparsely occupied), as pre-
dicted from the nucleosome positioning prediction algo-
rithm. Finally, the accurate nucleosome positioning in the
5S-G5E4 region 1 was confirmed by agarose nucleosome
gel shift assay performed on EcoRI cleaved 5S fragments
(Additional file 2: Figure S2D), demonstrating the forma-
tion of evenly spaced mononucleosomes of the same size
accurately positioned in known sites.
In order to compare the different retroviral INs enzymes
were all purified following similar purification procedure
derived from previously published work [47] and tested
under similar reaction conditions when possible. We first
selected reaction conditions allowing efficient concerted
integration for all the enzymes tested in the work. Two
distinct assays have been reported by different groups to
reproduce efficiently concerted integration in vitro. The
first assay uses long viral DNA substrates and PEG and al-
lows the detection of concerted integration in the absence
of LEDGF/p75 but show poor stimulation effect of the co-
factor [48,49]. The second assay developed by Cherepanov
group does not use PEG and allows the detection of
LEDGF/p75 dependent stimulation of concerted integra-
tion but poor full site integration in the absence of the co-
factor [50,51]. Consequently, since our main aim was to
analyze integration in the lack of cofactors, we have
chosen to use long donor substrates in presence of PEG.
These conditions allowed us to test HIV-1, PFV and MLV
INs using the same final protein concentration of 100 nM.
Blunt-end donor DNAs containing the specific viral ends
Figure 1 pBSK-Zeo-5S-G5E4 (p5S) acceptor plasmids used in the work. The 2.56 kb 5S-G5E4 fragment DNA for polynucleosome assembly
(PN) was previously described [62] and was cloned into the pBSP-zeo vector (A). This fragment is made of two times five repeats of 5S sequences
surrounding a central sequence containing five gal4 DNA binding sites and the adenovirus 2 E4 minimal promoter. The p5S vector thus contains
a region 1 containing nucleosome-positioning sequences and a region 2 containing the pBSK-zeo backbone. Each 5S fragment is separated by
two EcoRI restriction sites. Nucleosome occupancy prediction performed using the method previously described by [53] and used in [36] indicates
the formation on the chromatinized vector of two regions with different chromatin organization (regular and stable nucleosomes in the 5S-G5E4
region 1 and less organized and stable nucleosomes in the pBSK-Zeo backbone region 2 (B). Restriction inhibition assay demonstrates that the
two regions are not equally accessible since region 1 is highly protected when chromatinized whereas region 2 remains highly accessible for
restriction site cutting even in the nucleosomal structure (see Additional file 1: Figure S1).
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formed using naked or chromatinized p5S acceptor. As re-
ported in Figure 2A and B, under these conditions all the
enzymes were found highly active using their specific
donor DNA and the naked p5S receptor plasmid. Specific
isolation and quantification of the physiological FSI inte-
gration products (Figure 2C) show that the enzymes were
equally active leading to a similar amount of integrants
(200 to 225 per experiment). However, despite their simi-
lar activity on naked DNA, large differences were found in
their activity on nucleosomal templates. Indeed, in con-
trast to HIV-1, the activity of PFV and MLV INs were
strongly stimulated on chromatinized receptor plasmid
leading to a 4- to 5-fold increase in the integration prod-
ucts (Figure 2A as well as quantification in 2B and C). No
significant change in integration fidelity was found using
the chromatinized vector comparing to the naked one
(Additional file 3: Figure S3).To confirm that different retroviral INs could be af-
fected differently by chromatin in vitro¸ ASV enzyme was
tested under its previously reported optimal conditions
[52]. Under these conditions, ASV IN was found to be
more active on naked DNA than HIV-1, PFV and MLV
enzymes catalyzing the formation of a greater amount of
integration products (Figure 2A and quantification in 2B).
Cloning and quantification of the circular FSI forms, the
most representative for the physiological integration reac-
tion observed in cells, confirmed that ASV IN was more
active in vitro (Figure 2C) and preferentially displayed the
expected 6 bp target site duplication (Additional file 3:
Figure S3). However, despite its higher activity found on
naked DNA, ASV integration was strongly inhibited by
nucleosomes assembly as observed for HIV-1 IN (see
Figure 2A and quantification in 2B). Additionally, specific
quantification of the circular FSI products also revealed
a strong decrease in the number of integrants on nucleosomal
Figure 2 HIV-1, PFV, MLV and ASV in vitro integration on naked and chromatinized p5S vectors. Concerted integration assay was
performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or polynucleosomal vectors assembled with increasing
amounts of histones expressed as DNA/histones mass ratio (μg/μg) (1/1.1, lanes 2; 1/1.3, lanes 3) and either HIV-1, PFV, MLV (100nM) or ASV
(600 nM) integrases. The reaction products were loaded onto 1% agarose gel and a representative set of experiments is shown in the figure
(A). The position and structures of the donor substrate and different products obtained after half-site (HSI), full-site (FSI) and donor/donor
integration (d/d) are shown. The circular FSI + HSI and linear FSI products were quantified on gel using the ImageJ software and are shown
respectively in the left and right panels in (B). The circular FSI products were specifically quantified by cloning in bacteria and shown as the
number of ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked
vectors (C). All the values are shown as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number
of selected clones is also shown at the top of the histogram.
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Similar results were obtained using different enzyme con-
structs, preparations, purification procedure and various
viral DNA substrates (see data reported for HIV-1 IN in
Additional file 4: Figure S4).
To better ascertain the relationship between integra-
tion, nucleosomes positions and chromatin structure, we
mapped more precisely the integration sites obtained
from retroviral integrases on the different chromatin
structures of the acceptor plasmid.
Effect of nucleosomes density on in vitro HIV-1, PFV, ASV
and MLV integration selectivity
The integration site targeting in the two regions of the
plasmid differing in their nucleosomes density and sta-
bility was first studied. Fifty integrants previously ob-
tained with naked and chromatinized p5S acceptors
using HIV-1, PFV, ASV and MLV IN were cloned, se-
quenced and the positions of the integration sites werecompared. As shown in Figure 3, most of the HIV-1 in-
tegration sites mapped on the chromatinized templates
were found in the region of low nucleosome occupancy
outside the 5S-G5E4 nucleosome positioning region 1
(86% of total analyzed sites), thus confirming previously
reported results [36]. Similar profile was observed with
ASV integrase with a more drastic redistribution of the
integration sites in the lower nucleosome density region
of the chromatinized vector. However, in contrast to
HIV-1 and ASV integration, the 5S-G5E4 positioning re-
gion 1 of the plasmid containing dense nucleosomes was
not found refractory to PFV and MLV integration. In-
deed these INs were found to accommodate both re-
gions of the plasmid with a significant preference for the
nucleosome dense region 1 (64% of sites analyzed were
found within the 5S-G5E4 fragment for PFV and 74%
for MLV).
To correlate more precisely the nucleosomes positions
with integration sites we analyzed more in details their
Figure 3 Localization of the HIV-1, PFV, MLV and ASV integration sites in both regions of the naked or chromatinized acceptor DNA.
Fifty PFV, HIV-1, ASV and MLV integrants carrying the correct target DNA duplications (respectively 4, 5, 6 and 4 bp) were selected from the
concerted integration shown in Figure 2 using p5S vector, either under the naked structure or chromatinized with a DNA/histones ratio of 1/1.3.
The positions of the different integration events were identified and shown in region 1 or region 2. The values are plotted as the number of
ampicillin-, kanamycin- and tetracycline-resistant selected clones as a percentage of integration reaction control performed with naked vectors
and as the mean ± standard deviation (error bars) of at least three independent sets of experiments. The number of selected clones is also shown
at the top of the histogram. A Student test was performed on serial values and the significant p values are reported in the figure.
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somes assembled at known positions predicted from the
algorithm described in [53] (and derived from [54]) and
experimentally validated (see Additional file 2: Figure S2).
The analysis was performed on 50 integration sites pre-
viously selected within the 5S-G5E4 region for each
enzyme. PFV and MLV sites were found to be preferen-
tially enriched in regions of high probability of nucleo-
some presence (see Figure 4A and 4C), whereas no bias
in the integration site positions was found on the naked
version of the plasmid for both enzymes (Additional file 5:
Figure S5). The calculation of the mean nucleosome occu-
pancy found at the integration sites confirms a strong
preference of MLV and PFV integration for nucleosomes
in the dense region of the reconstituted chromatin tem-
plate (Figure 5A). Sequence bias was ruled out since
the integration in the naked plasmid did not show
such specific localization in regions favoring nucleosomes
positioning (Figure 5B). Consequently, our data show
that MLV and PFV in vitro integration reactions are
favored on nucleosomes localized in dense and stable
chromatin region.
HIV-1 and ASV integration sites carrying the physio-
logical duplications (respectively 5 and 6 bp) obtained
under the same reaction conditions and using the p5S
vector assembled with a similar 1/1.3 DNA/histones ra-
tio (w/w) were then analyzed. The integration experi-
ment was reproduced a sufficient number of times to
obtain a similar amount of 50 integrants carryingintegration sites in the 5S-G5E4 region for both en-
zymes. As shown in Figure 4B and D, a strong bias to-
ward regions of low nucleosome occupancy, especially
the linker regions separating the nucleosomes, was
found in the 5S-G5E4 region. The mean nucleosome oc-
cupancy found at the HIV-1 and ASV integration sites
was 2-fold lower than the global mean found for the
overall plasmid sequence (Figure 5A). Again, this distri-
bution was not due to a sequence bias since a random
distribution was found in the naked plasmid (Additional
file 5: Figure S5 and Figure 5B). This indicates that both
HIV-1 and ASV integration are preferred in regions con-
taining poorly dense nucleosomes and that nucleosomes
localized in organized and stable regions are not favored
substrates for HIV-1 and ASV in vitro integration in con-
trast to MLV and PFV.
As shown in Additional file 3: Figure S3 and Additional
file 6: Figure S6A HIV-1 IN also catalyzed in vitro integra-
tion events displaying 4 bp target site duplications, in
addition to the correct 5 bp duplications. As discussed
below and shown in [14], these integration events are as-
sumed to be catalyzed by differently structured intasomes.
While no bias was found in the distribution of the 4 bp in-
tegration loci in the naked DNA (Additional file 6: Figure
S6B), a strong bias for the 5S region was observed for
these events (Additional file 6: Figure S6C) with a strong
preference for nucleosomes dense regions of the plasmid.
Since these 4 bp and 5 bp integration events were cata-
lyzed by intasomes from the same enzyme preparation this
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sensitivity of the various INs for nucleosomes are not
due to differences in reaction conditions or activity.
Moreover these data also suggest that the differences
found in nucleosome sensitivity between the various
integrases are mainly due to local constraints in the
catalytic pocket of the various intasomes that define the
target DNA duplication.
In vitro PFV IN sensitivity to nucleosome is not dependent
on its N-terminal extension domain (NED)
Since MLV and PFV integrases both contain an add-
itional N-terminal extension domain (NED) compared
to HIV-1 IN and ASV [8], we wondered whether it could
be responsible for the difference in the impact of chro-
matin structures on in vitro integration. A PFV IN de-
leted for this NED domain was thus expressed and
purified according to the same procedure as for wt INFigure 4 Comparison of HIV-1, PFV, MLV and ASV integration sites an
and ASV (D) integrants carrying the correct target DNA duplication obtaine
a 1/1.3 DNA/histones ratio and localized in the 5S-G5E4 fragment were po
occupancy determined using the method previously described by [53] andand its in vitro integration activity was compared using
naked and chromatinized templates. Wt and the NED-
deleted INs were found to be equally active under stand-
ard conditions using the naked p5S acceptor plasmid, as
it was expected from previous data obtained using short
donor DNA [47]. This indicates that both enzymes share
a similar functional structure even on long donor DNA.
Analysis of the integration site structure also indicated
that both enzymes shared the same target site duplica-
tion of 4 bp (Additional file 3: Figure S3), confirming
that this duplication is mainly governed by the arrange-
ment of viral ends in the catalytic sites involved in the
strand transfer reaction.
When the two enzymes were assayed on a chromati-
nized p5S acceptor template under optimal stimulation
with regards to integration into naked vector, the same
stimulation profile was observed. Indeed, nucleosomes
induced a strong stimulation of all the hetero-reactiond nucleosome occupanc in vitro. Fifty PFV (A), HIV-1 (B), MLV (C)
d after integration assay carried on the p5S vector chromatinized with
sitioned onto the DNA sequence and compared to the nucleosome
used in [36].
Figure 5 Correlation between HIV-1, PFV, MLV and ASV integration sites and nucleosome occupancy means in vitro. The mean
nucleosome occupancy found at the integration site on chromatinized or naked plasmid was calculated and plotted respectively in (A) and (B).
The mean nucleosome occupancy of the overall plasmid is reported as dotted line. A Student test was performed on serial values and the
significant p values are reported in the figure.
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FSI (Figure 6A) and circular FSI + HSI (Figure 6B) prod-
ucts. Cloning and quantification of the physiological cir-
cular FSI integration products confirmed that both
enzymes were stimulated by nucleosomes assembled on
the target templates (Figure 6C). The position of the in-
tegration sites in the two regions of the p5S plasmid
showed a similar distribution between both enzymes
with a broad localization throughout the plasmid and
a significant preference for the 5S region (compare
Figure 6D and Figure 3). We next analyzed the PFV in-
tegration site localization in the nucleosome-enriched
5S-G5E4 region of the plasmid and compared it to the
predicted nucleosome position. As shown in Figure 6E,
the distribution of the delta NED enzyme was similar
to that of the wild type integrase (compare Figure 4A
and Figure 6E), whereas no relevant sequence biases
were detected in the naked vector (see nucleosome occu-
pancy means in Figure 6F). Taken together, our data dem-
onstrate that the NED domain from PFV integrase was
responsible neither for the nucleosomes mediated stimula-
tion of in vitro integration catalyzed by this enzyme, nor
for its in vitro selectivity toward nucleosomal DNA.
Comparison between integration sites in infected cells
and predicted nucleosome occupancy
In order to investigate whether the sensitivity to dense
nucleosomes regions found in vitro for the retroviral en-
zymes could be relevant in a more physiological context
we analyzed the positions of cellular integration sitesfrom two retroviruses showing distinct and opposite
in vitro selectivity. HIV-1 and MLV were chosen since
they present highly divergent in vitro and in vivo inte-
gration profiles. Furthermore their integration profiles in
infected cells were extensively reported and, thus, a suf-
ficient number of integration sites could be recovered
from literature allowing a statistically relevant analysis.
The sequence surrounding 41 435 and 32 631 non re-
dundant HIV-1 and MLV integration sites respectively ob-
tained in human infected cells and selected from previous
studies [55,56] were mapped into the human genome
and submitted to a nucleosome-position prediction algo-
rithm developed previously by Milani et al. [53]. This algo-
rithm was chosen since it has been shown to provide
predictions that are in good agreement with nucleosome po-
sitioning determined in vitro by physical and biochemical ap-
proaches [53,57,58]. This has been further validated on our
in vitro receptor templates by showing a good correlation
with the experimentally determined nucleosomes positions
(see Additional file 2: Figure S2). Actually, the performance
of this method is as good as the more commonly used ap-
proach developed by Segal and Widom’s groups [59] (the
mean Pearson correlation between genome-wide experi-
ments and prediction is > 0.75).
The probabilities of nucleosome occupancy were cal-
culated along the selected sequences and averaged using
the integration sites to align the sequences. As shown in
Figure 7A, both MLV and HIV-1 integration sites were
found locally associated with high nucleosome occu-
pancy probability (respectively 0.73 and 0.67) showing a
Figure 6 In vitro integration catalyzed by WT and delta NED PFV INs on naked and chromatinized p5S vectors. Concerted integration
assay was performed with 10 ng of donor DNA and 100 ng of p5S naked plasmids (lanes 1), or p5S polynucleosomalp5S vectors assembled
with a 1/1.1 DNA/histones ratio (μg/μg) either 90nM wt PFV IN or 90nM delta NED PFV IN. The reaction products were loaded on 1% agarose
gel and the linear FSI and circular FSI + HSI products were quantified on gel autoradiography using the ImageJsoftware and the values are
plotted respectively in (A) and (B). The circular FSI products were specifically quantified by cloning in bacteria and plotted as the number of
ampicillin-, kanamycin- and tetracycline-resistant selected clones in percentage of integration reaction control performed with naked vectors
(C). The positions of the different integration events were then identified by sequencing and plotted in region 1 or region 2 (D). Values correspond
to the mean ± standard deviation (error bars) of 3 independent sets of experiments. The number of selected clones is also shown at the top of the
histograms. Fifty integrants carrying the correct 4 bp target DNA duplication obtained after integration assay carried on the p5S vector chromatinized
with a 1/1.3 DNA/histones ratio were localized on the p5S sequence (E) and compared to the nucleosome occupancy determined using the method
previously described by [53] and used in [36]. The mean nucleosome occupancy found at the integration site on chromatinized or naked plasmid was
calculated and plotted respectively in (F). A Student test was performed on serial values: *p < 0.05.
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a nucleosome. Comparison between nucleosome occu-
pancy found at MLV and HIV-1 integration sites and the
global occupancy mean calculated for the entire genome,
or the occupancy found at randomly generated insertion
sites, showed a preference of MLV for more dense re-
gion whereas HIV-1 integration is favored in regions of
lower occupancy (Figure 7B). A deeper analyses of the
chromatin density directly surrounding the integration
site showed a global increase in the average in vivo
nucleosome occupancy within the −5000 to +5000 bprange surrounding the MLV integration sites while a glo-
bal decrease of the average nucleosome occupancy was
observed around the HIV-1 insertion loci (Figure 7C).
Moreover, comparison of the mean occupancy found at
distal sites (1 kbp from the integration site) for MLV and
HIV-1 also showed that MLV integration was preferred
in region of higher nucleosome density than HIV-1
(0.739 for MLV and 0.679 for HIV-1, see Figure 7D).
Consequently, our results indicate a preferential inte-
gration into a nucleosome in infected cells for both
MLV and HIV-1. However the nucleosome targeted by
Figure 7 Correlation between in vivo HIV-1 and MLV integration sites positions and nucleosome occupancy. 41 435 HIV-1 integration
loci obtained from [12], and 32 631 MLV integration sites obtained from [56] were plotted to human genome and submitted to the
nucleosome-positioning prediction analysis set up previously [39]. The means of nucleosome occupancy surrounding the integration site
(between −250 bp and 250 bp) are reported in (A). The means of nucleosome occupancy at the integration site are reported in (B) for MLV,
HIV-1 and randomly generated insertion sites. The means of nucleosome occupancy in the region between −5 000 bp to + 5 000 bp from the
integration site are reported in (C). Results are the means of the analyses performed from the 41435 HIV-1 and 32 361 MLV integrants. The
means of nucleosomes occupancy in −1000 to 0, −500 to 0, 0 to 500 and 0 to 1000 bp regions surrounding the integration sites are reported in
(D). Dotted lines represent the position of the integration sites and the global occupancy mean calculated for the entire genome.
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tin contexts. This shows that MLV and HIV-1 present
distinct and opposite preferences for chromatin density
surrounding the nucleosomal integration site supporting
a modulation of retroviral integration by the chromatin
density surrounding the targeted nucleosome as sug-
gested by our in vitro data.
Discussion and conclusion
Retroviral integration selectivity is thought to be regu-
lated by viral and cellular determinants and some of
them are specific of the retrovirus. Among all retrovi-
ruses, the IN protein and component of the Gag poly-
protein have been shown to be involved in integration
selectivity [60]. Interactions between these viral compo-
nents and chromatin structure are thought to affect theselectivity of retroviral integrases. Early experiments per-
formed in vitro using recombinant enzymes and recon-
stituted nucleosomal DNA indicated that nucleosomes
were a preferential target for in vitro integration [42-46].
Compaction of a polynucleosome template by histone
H1 was also shown to affect differently integration cata-
lysed by two different INs (HIV and ASV) [52]. Con-
certed integration assays were more recently employed
to investigate the influence of chromatin structure on in-
tegration site selectivity [61,36]. These data confirmed
that HIV-1 global integration was favoured into nucleo-
somal DNA [62] and demonstrated that the chromatin
structure and dynamics could influence the physiological
full-site integration reaction [36]. This was then con-
firmed in a selectivity assay using a mixture of vectors
with different nucleosome densities indicating that full-
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nucleosomal template [57]. Taken together these data
obtained in different nucleosomal models with different
chromatin structures and various retroviral integrases, in
addition to the differences found in in vivo integration
selectivity from one retrovirus to another one suggest
that intrinsic properties of the viral intasome as well as
the structure, density and dynamics of the chromatin
around the targeted nucleosome play an important role
in the integration site selection.
To determine the importance of this regulation in the
local association of the intasome with nucleosomes, we
focused our present work on the intrinsic properties of
different retroviral integrases that can affect the final
intasome•nucleosomal DNA functional interaction. We
have chosen various retroviral integrases belonging to
distinct genera displaying different in vivo selectivity and
target sequence duplications marks. These enzymes were
tested in vitro for their integration activity on chromati-
nized template in the lack of cellular cofactors. For this
purpose we have selected reaction conditions allowing
efficient concerted integration for all the enzymes tested
in the work without the need of additional cofactors.
Two main in vitro integration conditions were described
in the literature using either long donor substrates, PEG
and low enzyme concentration [48,49] either short
donor substrate without PEG but requiring higher en-
zyme concentration and cellular cofactors, as LEDGF/
p75, for efficient integration activity [50]. Since our main
aim was to study the impact of chromatin on retroviral
INs without their cofactors we have chosen conditions
including PEG and allowing efficient integration for all
the enzymes tested. To avoid biases due to the choice of
these specific reaction conditions (presence of non-
physiological components as PEG) we focused our ana-
lyses on the physiological full site integration products
catalyzed by the retroviral enzyme. Indeed, these events
are undoubtedly catalyzed only by functional intasomes
and, thus, the experimental conditions were not expected
to impact the choice of the integration sites. Under these
conditions, we found that HIV-1, PFV, ASV and MLV en-
zymes were not affected equally by nucleosomes. PFV and
MLV integration efficiencies were increased in a chromati-
nized template, whereas HIV-1 and ASV integrations were
inhibited by stable and compact chromatin. Furthermore
PFV and MLV integration events occurred preferentially
in the 5S-G5E4 positioning region of our plasmid with a
significant preference for the stably associated nucleo-
somes. In contrast, HIV-1 and ASV integration events
were found preferred in regions of low nucleosomes occu-
pancy especially in the less dense region of our acceptor
DNA. These differences were not found dependent on the
purification procedure nor reaction conditions since same
profiles were always found for the various retroviral INswhen purified or tested in distinct conditions (concentra-
tion, presence of detergent, use of donor DNA containing
various viral U3/U5 ends combination, see Additional file
4: Figure S4). Even if we can not completely rule out any
bias link to the reaction conditions selected for the study
(presence of PEG for example) the focus of the analysis on
the full site integration products is expected to limit this
bias. Indeed, even if the formation of a catalytically profi-
cient intasome remains a limiting step with regard to inte-
gration efficacy, the reaction conditions should only affect
the amount of functional intasomes formed and not the
choice of the integration site dictated both the architecture
of the intasome and the local target DNA structure. This
is supported by the fact that the differences in the sensitiv-
ity toward nucleosomal density were found independent
on the efficiency of concerted integration. Indeed, ASV
was found more active than PFV on naked DNA but was
also found inhibited by stable chromatin as HIV-1 (less ac-
tive than PFV in catalyzing concerted integration events).
Furthermore, the differences found between HIV-1/ASV
and PFV/MLV INs were not dependent on the presence of
the additional NED domain in PFV, indicating that the dif-
ferential effect of chromatin on these enzymes in vitro is
probably mainly due to local differences in the architec-
ture of the catalytic pocket within the functional inta-
somes and not to global structural differences between the
complexes. This is supported by the differences found be-
tween the HIV-1 integration reactions, leading to different
staggered cuts in the target DNA. Indeed we previously
showed that full site and half site integration could be im-
pacted differently by nucleosome assembly in vitro [36].
Interestingly, differences were also found in this work re-
garding the effect of nucleosomes on the selectivity of
HIV-1 integration reactions leading to 4 bp, 5 bp or 6 bp
target DNA duplications (see Additional file 6: Figure S6).
Indeed, while 5 bp and 6 bp integration reactions were
highly disfavored in the stable chromatin region of the
acceptor plasmid, 4 bp events were more widespread in
the backbone with a clear preference for the high nu-
cleosome density region. Since the ratio of chromatin
assembly did not influence the proportion of these
“non-physiological” integration events (Additional file
3: Figure S3), the latter are most likely catalyzed by ab-
errant intasomes structures as previously demonstrated
[14]. Consequently, the most reasonable hypothesis that
could account for their enrichment in nucleosome
dense regions would be that the IN sensitivity toward
chromatin is mainly driven by the structure of the IN/
viral DNA complex that can or cannot accommodate
nucleosomal DNA depending on the relative position of
the active sites.
Because no bias in the PFV integration site positions
was found in the naked version of the acceptor plasmid
(Figure 5 and Additional file 5: Figure S5), our data
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compacted chromatin, in contrast to HIV-1 and ASV
INs. The structure of the target DNA, and especially its
bending, in the retroviral intasome is expected to be
governed by the space between the two catalytic sites in-
volved in the staggered cut leading to different target
DNA duplication size [8-10]. This target DNA curvature
varying in the different intasomes could, thus, impact
the nucleosome sensitivity of the retroviral enzymes.
This is supported by the differences found between the
retroviral enzymes tested here catalyzing different target
sequence duplication and by the differential effect of
nucleosomes on the selectivity of HIV-1 integration reac-
tions leading to 4 bp, 5 bp or 6 bp target DNA duplication.
Interestingly, recent work highlighted the importance of
the presence of flexible pyrimidine/purine steps between
the attacked phosphate groups during the strand transfer
reaction in promoting DNA bending and thus allowing
the target DNA to adopt a conformation compatible with
its capture by the intasome, with a minimal energetic ex-
pense [38] and reviewed in [39]. The extent to which the
target DNA must be bent depends on the relative position
of the IN active sites responsible for the pair-wise strand
transfer reaction within the intasome. In the context of a
nucleosome, the target DNA is already structurally con-
strained, therefore, its engagement into the target DNA
capture complex would depend on the conformational re-
arrangements required, hence on the intasome structure.
Indeed, this bending of the target DNA in linked to the
position of the IN active sites for the pair-wise strand
transfer reaction. This bendability is also expected to be
affected by the nucleosome structure and chromatin envir-
onment which can allow DNA extrusion and facilitate its
optimal curvature for integration. Both intrinsic structural
properties of the enzymes and nucleosome structure may,
thus, play an important role in the final integration site se-
lection. Especially all these data confirm that intasome
structural constraints, as the distance between catalytic
sites, participate in the local selection of the integration
site within chromatin by modulating the functional affinity
of the integration complex with nucleosomal DNA in spe-
cific chromatin structure.
Additional interactions between intasomes and nucle-
osomes could also be modulated by the chromatin dens-
ity at the insertion locus. Especially histone tails could
be more or less accessible depending on the compaction
of the surrounding nucleosomes. Comparison of the re-
lationship between integration sites from two retroviral
paradigms (HIV- and MLV) and nucleosome occupancy
in cells (Figure 7) indicates that, both retroviral insertion
loci were associated locally with high nucleosome occu-
pancy probability. This suggests that in both cases the
selected integration site is probably occupied by a nu-
cleosome which is in contrast to what was observed forHIV-1 in nucleosome dense regions of the receptor tem-
plates used in vitro. The apparent discrepancy found for
the local preference of HIV-1 IN for nucleosomes be-
tween in vitro and in vivo data could be due to the fact
that, in the cells, additional remodeling machineries
could be involved during the integration process, espe-
cially in the highly transcribed regions of viral DNA in-
sertion as supported by previous data [36], as well as the
lack of cellular tethering cofactors in the biochemical as-
says used in this work. However, when the chromatin
structure surrounding the integration sites was analyzed
a significant preference for region of higher nucleosome
occupancy was found for MLV comparing to HIV-1 IN
that preferred less dense regions of the host DNA. This
cellular phenotype appears compatible with the intrinsic
sensitivity of the retroviral enzymes toward nucleosomes
and their capability to accommodate dense or less dense
chromatin structure as found in vitro. Thus, even in cel-
lular context, when targeting factors are present, the IN-
specific preference found in vitro for regions of variable
nucleosomes density can also be detected. Even if the
role of the IN cofactors in the local association between
intasome and nucleosome remains to be established, our
data suggests that the intrinsic sensitivity of retroviral
INs toward specific chromatin structure may play an im-
portant role in the local selection of the integration site in
infected cells in addition to their targeting toward specific
region of the host genome by the host cofactors. Taken to-
gether all these data support a preferential retroviral inte-
gration into a nucleosome but in different chromatin
contexts in a mechanism that will depend both on the
integrases structures and modulations by the chromatin
environment of the targeted nucleosome.
Consequently, the retroviral integration targeting toward
nucleosomes appears as a multiple steps process that in-
cludes a targeting of the retroviral intasome toward suit-
able regions of the chromatin as promoter or gene body
due to specific interaction between INs and their targeting
factors as LEDGF/P75 or BET proteins; and a more local
targeting toward the suitable integration site governed
by the intrinsic sensitivity of the retroviral INs to spe-
cific target DNA bending and chromatin density sur-
rounding the integration locus. These last steps are
expected to be governed by the physical constraints
within the intasomes modulating its functional inter-
action with the targeted nucleosome. This model is
strongly supported by several data from the literature.
Knock out experiments have previously established that
LEDGF/p75 was not essential for HIV-1 integration
in vivo [33] and, in the absence of LEDGF/p75, the weak
consensus associated with HIV-1 integration is main-
tained and integration is (though to a lower extent) still
associated to active transcription units. Furthermore, a
C-terminal deletion derivative of MLV IN, unable to
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in vivo, and does not show changes in its local integra-
tion selectivity [37]. These data, in addition to our work,
support the dependence on the structure of the inta-
some in its functional association with nucleosomes
after the initial targeting step mediated by cellular cofac-
tors (e.g. LEDGF/p75 and BET proteins). Consequently,
taken together, these results point out the retroviral inta-
some, itself, as an important actor in the integration site
selection process.
Other additional key parameters are also known to be
important in integration site selection, such as the three
dimensional localization of the chromatin in the nucleus
in comparison to the PIC nuclear entry site [63] or the in-
volvement of chromatin remodeling proteins that can be
found in the integration locus area and expected to affect
the nucleosomes stability. Global analyses of the HIV-1 in-
tegration site showed that integration occurs in the active
region of the chromatin carrying nucleosomes bearing the
H3K36me3 modification that promotes transcription and
remodeling [55]. In silico comparison of the integration
sites found in infected cells and nucleosome positioning
show that the process occurs in a region of low nucleo-
somes density within the chromatin [36]. These data sug-
gest that, for HIV-1 integration to occur, a nucleosomal
DNA structure could be required at the integration site
but in a context of dynamic chromatin. In this context,
the DNA extrusion from the nucleosome is expected to be
facilitated, especially during remodeling, allowing the re-
quired degree of bending. The position of the integration
sites on the surface of the nucleosome [55] also suggests
that other proteins inducing local remodeling of the DNA
in the nucleosome nucleoprotein complex and/or supple-
mentary intasome/nucleosome interactions could be in-
volved, in addition to the anchoring factor LEDGF/p75.
This would makes the cellular integration process more
complex than just involving a direct binding of the retro-
viral intasomes to the DNA at the nucleosome surface and
would highlight the importance of the chromatin context
around the targeted nucleosome modulating additional
contacts between the integration partners.
Methods
Proteins
PFV and ASV INs were purified from E.coli BL21 bacteria
using the same procedure than described previously [47]
[64]. HIV-1 IN was purified either from bacteria using the
same procedure as described for PFV enzyme [47] either
from yeast was purified as previously reported [65]. MLV
IN was purified using the procedure reported by [66].
DNA substrates
Both pBSK-5SG5E4 (p5S) target and HIV-1 donor DNA
were described previously [36]. The ASV and PFV 250 bpdonor DNA were obtained by amplifying the SupF-
containing fragment from the pUC19-SupF vector de-
scribed before [14] using primers containing either the
20 bp from the ASV U3 viral ends or PFV U5 viral ends
or U3 and U5 MLV ends:
ASV_U3_SupF5′ 5′AATGTAGTCTTATGCAATACT
CTTGTAGTCTTGCAATTAACGTTGCCCGGATC
CGGTCGCGC 3′, ASV_U3_SupF3′ 5′AATGTAGTCT
TATGCAATACTCTTGTAGTCTTGCAAGCGGCG
CGTCATTTGATATGATGCG 3′PFVSupF5′ 5′ ATT
GTCATGGAATTTTGTATATTGATTATCCTTTAA
CGTTGCCCGGATCCGGTCGCGC 3′, PFVSupF3′
5′ ATTGTCATGGAATTTTGTATATTGATTATCC
TGCGGCGCGTCATTTGATATGATGCG 3′. MLV
SupF5′ 5′TATGAAAGACCCCACCTGTAGTTAACG
TTGCCCGGATCCGGTCGCGC 3′
MLVSupF3′ 5′ TATGAAAGACCCCCGCTGACGCG
GCGCGTCATTTGATATGATGCG 3′, respectively.
The amplified fragments were purified from a 1% agar-
ose gel using the PROMEGA Wizard SV gel and PCR
cleanup system and 5′ radiolabelled using the T4 poly-
nucleotide DNA kinase (PROMEGA). The different
donor DNA are described in Additional file 1: Figure S1.
Polynucleosome templates were assembled using puri-
fied HeLa core histones (H3, H4, H2A and H2B) [67] by
gradient salt dialysis [68]. Structure of regions I and II
of the p5S vector was previously checked by ab initio
prediction of nucleosome occupancy throughout the
DNA sequence performed by computing the free-energy
landscape associated with the bending of DNA around
histone octamers to form nucleosomes [36] (see Figure 1).
Nucleosome assembly was checked by DNase I protection,
REA assay and mono- and di-nucleosome gel shift, as done
before [36] and described in Additional file 2: Figure S2.
Concerted integration
Standard concerted integration reactions were optimized
from conditions described previously [65] in order to
allow efficient catalyse of full site integration reaction in
absence of other cellular cofactors. For this purpose we
used 5′-end-labeled donor DNA (10 ng) and naked or
chromatinized circular target DNA plasmids (50 ng) and
purified INs (typically 100 nM) previously diluted to
1 μM in 1 M NaCl, 20 mM HEPES 1 M pH7, 10 mM
DTT for 30 minutes on ice. Then 200 nM IN were incu-
bated 30 minutes on ice with 10 ng of donor DNA and
50 ng of acceptor plasmid in 5 μl final volume. Reaction
was then started by adding 5 μl of the reaction buffer
(final concentrations 100nM IN, 15% DMSO, 8% PEG,
10 mM MgCl2, 20 μM ZnCl2, 100 mM NaCl, 10 mM
DTT). After the reaction, integration products were
loaded onto 1% agarose gel. The gel was then dried and
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tivity was performed using the Image J software with the
following procedure: the bands corresponding to the
free substrate (S), the donor/donor (d/d), linear FSI
(FSI) and circular HSI + FSI (HSI + FSI) were quantified.
The percentage of HSI + FSI integration activity was calcu-
lated as (HSI + FSI)/[(FSI) + (HSI + FSI) + (d/d) + (S)] × 100.
Percentage of FSI integration activity was determined as
(FSI)/[(FSI) + (HSI + FSI) + (d/d) + (S)] × 100. The global
FSI activity was estimated from the amount of linear
FSI products which has previously been shown to be
representative of the circular FSI form. The circular FSI
reaction efficiency was then quantified by cloning the
integration products in bacteria according to the same
protocol as described previously [14] with some minor
modifications. The integration reaction performed with
unlabelled donor DNA and the corresponding acceptor
plasmids was 15 times scaled up and the integration prod-
ucts were loaded on 1% agarose gel after deproteinization
using protease K 1 mg/ml (ROCHE) and phenol/chloro-
form/isoamyl alcohol (24/25/1, v/v/v). The open circular
forms of the products were purified using the PROMEGA
Wizard SV gel and PCR cleanup system and 2–5 μl ali-
quots of the purified DNA were used to transform electro-
competent MC1060/P3 E. coli strain which contained
ampicillin-, tetracycline- and kanamycin-resistance genes.
Integration clones carrying the supF gene were selected in
the presence of 40 μg/ml ampicillin, 10 μg/ml tetracycline
and 15 μg/ml kanamycin. Integration loci determination
was performed by isolating plasmids from triple-resistant
colonies and PCR sequencing (ABI Prism big dye termin-
ator cycle sequencing ready reaction kit, Applied Biosys-
tems) using the corresponding HIV-1, PFV, ASV and MLV
primers described above. The number of experiments was
adjusted to reach the required amount of integrants for
statistically significant analyses.
Nucleosome occupancy prediction
Nucleosome occupancy prediction was determined using
the method previously described in [53] and used in [36].
Additional files
Additional file 1: Figure S1. Structure of the viral donor substrates. All
the donor DNA contain the SupF amber suppressor gene required for
cloning of the integrants and carry the specific HIV-1, PFV, ASV or MLV U3
or U5 viral ends sequences.
Additional file 2: Figure S2. Structure of the pBSK-zeo-5S-G5E4 (p5S)
acceptor plasmid. A- Nucleosome occupancy prediction and restriction
site positions determined using the method previously described by
[53] and used in [36]. Restriction sites localized either in the 5S-G5E4
fragment or in the pBSK-Zeo (pZeo) backbone were plotted in the graph.
The number of sites is also reported as well as their position in the vector
sequence. B- Analysis of the global nucleosomal structure of the plasmid
by DNase 1 protection. 200 ng of naked p5S (lanes 1) or chromatinized
with 1/1.1 (lanes 2) or 1/1.3 (lanes 3) DNA histones ratios were digestedusing 0.15 units of DNase 1 for 2 minutes at 37°C. Samples were then
submitted to deproteinization using a 24/25/1 (v/v/v) phenol/chloroform/
isoamyl alcohol solution and loaded onto 1% agarose gel 1% SybrSafe.
The percentage of cleaved DNA was quantified and plotted in the graph.
C- Restriction enzyme assay analysis of the p5S nucleosomal structure.
200 ng of naked p5S (lanes 1) or chromatinized with 1/1.1 (lanes 2) or 1/1.3
(lanes 3) DNA histone ratios were digested with 1 unit of the corresponding
restriction enzyme for 30 minutes at 37°C. The product was then loaded
onto 1% agarose gel 1% SybrSafe and the restriction band was quantified
using ImageJ software and plotted as percentage of DNA cut. Enzymes
cleaving in the 5S-G5E4 region on a nucleosome, in the linker sequence or
in the pZeo backbone were chosen. D- Agarose nucleosome gel shift assay.
200 ng of naked p5S (lanes 1) or chromatinized with 1/1.1 (lanes 2) or 1/1.3
(lanes 3) DNA histones ratios were digested by EcoRI and loaded onto 0.8%
agarose gel under non-denaturating conditions. The position of the free
nucleosome positioning fragment is plotted (free DNA) as well as the
position of the mononucleosome (MN) and polynucleosome (PN) fragments.
Additional file 3: Figure S3. In vitro integration “fidelity” of the
different retroviral integrases studied. The target site duplications found
in integrants clones selected after integration assay performed in p5S
naked or 1/1.3 chromatinized vector were sequenced and plotted for all
integrases. The percentage of clones carrying the corresponding
duplication is reported as the mean of 3 independent experiments.
Additional file 4: Figure S4. A- Effect of the integrase expression and
purification conditions on in vitro concerted integration. HIV-1 expressed
in bacteria or yeast as native enzyme or Ct (His)6 tag fusion protein
purified following the same protocol than PFV integrase were assayed
on standard in vitro concerted integration on the p5S naked or
chromatinized with 1/1.1 or 1/1.3 DNA/histones ratios. After separating
of the integration products on agarose gels the different forms were
quantified using ImageJ and reported as percentage of integration (100%
correspond to the integration activity found on naked DNA). Results are
reported as the mean ± standard deviation (error bars) of at least three
independent sets of experiments. B- Effect of the viral DNA sequence in
the donor DNA on in vitro concerted integration. Concerted integration
assays were performed using HIV-1 IN and viral donor DNA containing
either U3/U5, U3/U3 or U5/U5 viral ends sequence. After separating of
the integration products on agarose gels the different forms were
quantified using ImageJ and reported as percentage of integration
(100% correspond to the integration activity found on naked DNA).
Results are reported as the mean ± standard deviation (error bars) of at
least three independent sets of experiments.
Additional file 5: Figure S5. Distribution of PFV (A), HIV-1 (B), MLV (C)
and ASV (D) integration sites on naked pBSK-zeo-G5E4 (p5S) vector. Fifty
integrants carrying the correct target DNA duplication obtained after
integration assay carried on the naked p5S vector localized in the
5S-G5E4 fragment were positioned the DNA sequence and compared
to the nucleosome occupancy determined using the method previously
described by [53] and used in [36].
Additional file 6: Figure S6. HIV-1 integration products formed in vitro
are differently affected by the nucleosomal DNA structure. Two hundred
selected clones obtained after HIV-1 integration in naked and chromatinized
vectors were sequenced and the structure of the target DNA duplication
found at the integration locus was shown as percentage clones carrying
correct 5 bp duplications, 4, 6 bp duplications and other structures (A). The
positions of the different integration events were identified and shown in
region 1 or region 2 in the naked (B) or nucleosomal acceptor plasmid (C).
The values correspond to the mean ± standard deviation (error bars) of 3 to
6 independent sets of experiments. A Student test was performed on serial
values and the significant p values are reported in the figure.
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